Allogeneic bone marrow transplantation for CML: A report from the International Bone Marrow Transplant Registry

Bone Marrow Transplantation

Volumn 17, Issue SUPPL. 3, 1996, Pages

  Horowitz, M M ^a   Rowlings, P A ^a   Passweg, J R ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Bone marrow transplant; Chronic myelogenous leukemia

Indexed keywords

INTERFERON;

ALLOGENIC BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CONFERENCE PAPER; DATA BASE; HLA MATCHING; HUMAN; MORTALITY; PRIORITY JOURNAL; REGISTER; REMISSION; TREATMENT OUTCOME;

BONE MARROW TRANSPLANTATION; HLA ANTIGENS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; RECURRENCE; REGISTRIES; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029952614     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Bortin MM, Horowitz MM, Rimm AA. Increasing utilization of allogeneic bone marrow transplantation. III. Results of the 1988-1990 survey. Ann Intern Med 1992; 116: 505-512.
2. Thomas ED, Clift RA. Indications for marrow transplantation in chronic myelogenous leukemia. Blood 1989; 73: 861-864.
3. Silberman G, Crosse MG, Peterson EA et al. Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries. New Engl J Med 1994; 331: 1063-1067.
4. Thomas ED, Clift RA, Fefer A et al. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med 1986; 104: 155-163.
5. Goldman JM, Szydlo R, Horowitz MM et al. for the Advisory Committee of the IBMTR. Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood 1993; 82: 2235-2238.
6. Gale RP, Horowitz MM, Ash RC et al. Identical-twin bone marrow transplants for leukemia. Ann Intern Med 1994; 120: 646-652.
7. Horowitz MM, Gale RP, Sondel PM et al. Graft-versusleukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.
8. Kolb HJ, Mittermuller J, Clemm C et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2465.
9. Porter DL, Roth MS, McGarigle C et al. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. New Engl J Med 1994; 330: 100-106.
10. Drobyski WR, Keever CA, Roth MS et al. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood 1993; 82: 2310-2318.